OBJECTIVES: To evaluate the impact of pulmonary emphysema (PE) on the incidence and severity of radiation pneumonitis (RP) in patients with lung and mediastinal tumours. METHODS: 92 patients were enrolled. Involved-field radiation therapy (non-small cell carcinoma or mediastinal tumours in 69 patients; median 70 Gy) and accelerated hyperfractionation (limited disease small cell carcinoma in 23 patients; median 45 Gy) were performed. Common Terminology Criteria for Adverse Events v.3.0 was used to evaluate RP and the relationship with the percentage of pulmonary volume irradiated to >20 Gy (V20) and PE. PE was diagnosed by the presence of low-attenuation areas (LAAs) on CT scans and was classified into Grades 0-4 according to the extent of the LAAs. RESULTS: The median follow-up time was 16 months. The 6-month cumulative incidence of RP at Grade 3 or greater was 7.7% and 34.1% in patients with a V20 of <25% and ≥25%, respectively (p=0.017). In patients with PE Grades 0, 1, 2 and 3 or greater, the incidence of RP was 16.5%, 9.1%, 8.6% and 54.0%, respectively. As the PE Grade increased, the incidence of RP also increased significantly. CONCLUSION: The incidence and severity of RP are significantly higher in patients with a high V20 value as well as in those with severe PE.
OBJECTIVES: To evaluate the impact of pulmonary emphysema (PE) on the incidence and severity of radiation pneumonitis (RP) in patients with lung and mediastinal tumours. METHODS: 92 patients were enrolled. Involved-field radiation therapy (non-small cell carcinoma or mediastinal tumours in 69 patients; median 70 Gy) and accelerated hyperfractionation (limited disease small cell carcinoma in 23 patients; median 45 Gy) were performed. Common Terminology Criteria for Adverse Events v.3.0 was used to evaluate RP and the relationship with the percentage of pulmonary volume irradiated to >20 Gy (V20) and PE. PE was diagnosed by the presence of low-attenuation areas (LAAs) on CT scans and was classified into Grades 0-4 according to the extent of the LAAs. RESULTS: The median follow-up time was 16 months. The 6-month cumulative incidence of RP at Grade 3 or greater was 7.7% and 34.1% in patients with a V20 of <25% and ≥25%, respectively (p=0.017). In patients with PE Grades 0, 1, 2 and 3 or greater, the incidence of RP was 16.5%, 9.1%, 8.6% and 54.0%, respectively. As the PE Grade increased, the incidence of RP also increased significantly. CONCLUSION: The incidence and severity of RP are significantly higher in patients with a high V20 value as well as in those with severe PE.
Authors: Zafer Kocak; Elizabeth S Evans; Su-Min Zhou; Keith L Miller; Rodney J Folz; Timothy D Shafman; Lawrence B Marks Journal: Int J Radiat Oncol Biol Phys Date: 2005-07-01 Impact factor: 7.038
Authors: Ellen D Yorke; Andrew Jackson; Kenneth E Rosenzweig; Louise Braban; Steven A Leibel; C Clifton Ling Journal: Int J Radiat Oncol Biol Phys Date: 2005-06-04 Impact factor: 7.038
Authors: Feng-Ming Kong; James A Hayman; Kent A Griffith; Gregory P Kalemkerian; Douglas Arenberg; Susan Lyons; Andrew Turrisi; Allen Lichter; Benedick Fraass; Avraham Eisbruch; Theodore S Lawrence; Randall K Ten Haken Journal: Int J Radiat Oncol Biol Phys Date: 2006-05-02 Impact factor: 7.038
Authors: Gerben R Borst; Katrien De Jaeger; José S A Belderbos; Sjaak A Burgers; Joos V Lebesque Journal: Int J Radiat Oncol Biol Phys Date: 2005-07-01 Impact factor: 7.038
Authors: M V Graham; J A Purdy; B Emami; W Harms; W Bosch; M A Lockett; C A Perez Journal: Int J Radiat Oncol Biol Phys Date: 1999-09-01 Impact factor: 7.038
Authors: Qian Zhang; Xiao Li Yu; Wei Gang Hu; Jia Yi Chen; Jia Zhou Wang; Jin Song Ye; Xiao Mao Guo Journal: Radiol Oncol Date: 2015-03-03 Impact factor: 2.991